LEADER 01252nam--2200409---450- 001 990000573230203316 005 20091026115537.0 010 $a90-411-0347-3 035 $a0057323 035 $aUSA010057323 035 $a(ALEPH)000057323USA01 035 $a0057323 100 $a20010718d1997----km-y0itay0103----ba 101 $amul. 102 $aNL 105 $a||||||||001yy 200 1 $aEurope$eand refugees$fa challenge?$dL'Europe et les réfugies$eun defi$fedited by Jean-Yves Carlier and Dirk Vanheule 210 $aThe Hague$cKluwer Law international$dc1997 215 $aXI, 280 p.$d25 cm 410 $12001 461 1$1001-------$12001 606 0 $aEmigranti politici$yEuropa 606 0 $aAsilo 676 $a342.4083 702 1$aCARLIER,$bJean-Yves 702 1$aVANHEULE,$bDirk 801 0$aIT$bsalbc$gISBD 912 $a990000573230203316 951 $aXXIII.4.K. 447 (IG VIII 12 ING 858)$b18312 G$cXXIII.4.K. 447 (IG VIII 12 ING)$d00246146 959 $aBK 969 $aGIU 979 $aPATTY$b90$c20010718$lUSA01$h1707 979 $c20020403$lUSA01$h1706 979 $aPATRY$b90$c20040406$lUSA01$h1640 979 $aRSIAV5$b90$c20091026$lUSA01$h1155 996 $aEUROPE$9112629 997 $aUNISA LEADER 01301nam--2200361---450 001 990001789980203316 005 20210304090154.0 035 $a000178998 035 $aUSA01000178998 035 $a(ALEPH)000178998USA01 035 $a000178998 100 $a20040624d1971----km-y0itay0103----ba 101 0 $aita 102 $aIT 105 $a||||||||001yy 200 1 $aMemorie$fLuigi Federico Menabrea$ga cura di Letterio Briguglio e di Luigi Bulferetti$gopera compiuta in collaborazione con l'Istituto italiano per la storia della tecnica e pubblicata con il contributo finanziario del Consiglio nazionale delle ricerche e della Domus Galileiana di Pisa 210 $a[Firenze]$cGiunti-G. Barbera$d1971 215 $aLXII, 228 p.$d24 cm 225 2 $aPubblicazioni di storia della tecnica$hSez. 3$iDocumenti 410 0$12001$aPubblicazioni di storia della tecnica$hSez. 3$iDocumenti 454 1$12001 461 1$1001-------$12001 676 $a945.080924 700 1$aMENABREA,$bLuigi Federico$05874 702 1$aBRIGUGLIO,$bLetterio 702 1$aBULFERETTI,$bLuigi 801 0$aIT$bsalbc$gISBD 912 $a990001789980203316 951 $aX.3.A. 891(III E COLL. 82/2)$b76529 L.M.$cIII E COLL. 959 $aBK 969 $aUMA 996 $aMemorie$9951344 997 $aUNISA LEADER 07317nam 22006255 450 001 9910760288503321 005 20251204104221.0 010 $a3-031-12199-6 024 7 $a10.1007/978-3-031-12199-9 035 $a(CKB)28644474500041 035 $a(MiAaPQ)EBC30848427 035 $a(Au-PeEL)EBL30848427 035 $a(DE-He213)978-3-031-12199-9 035 $a(PPN)272916536 035 $a(EXLCZ)9928644474500041 100 $a20231031d2024 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aAnti-Viral Metabolites from Medicinal Plants /$fedited by Dilipkumar Pal 205 $a1st ed. 2024. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2024. 215 $a1 online resource (1134 pages) 225 1 $aReference Series in Phytochemistry,$x2511-8358 311 08$a9783031121982 327 $aChapter 1 Introduction of medicinal plants as source of anti-viral metabolite(s), effects on health and general adverse effects -- Chapter 2:General plants showing anti-viral activity giving emphasis on CDRI?s biological screening programme -- Chapter 3: Classification of medicinal plants having anti-viral activity as per (i) family and (ii) types of viral infections -- Chapter 4: Ethnopharmacology, Chemistry, Clinical and preclinical studies focusing on use of different medicinal plants against Herpes simplex virus (HSV) Type 1 infections -- Chapter 5: Ethnopharmacology, Chemistry, Clinical and preclinical studies focusing on use of different medicinal plants against Herpes simplex virus (HSV) Type 2 infections -- Chapter 6: Role of various medicinal plants against in HIV infection in human with possible mechanism of action and functions of secondary metabolites -- Chapter 7: Ethnopharmacology, chemistry, clinical and preclinical studies focusing on use of different medicinal plants against Hepatitis B infections -- Chapter 8: Antiviral effects of different medicinal plants against Hepatitis C (HCV) infection: Role of phytochemicals -- Chapter 9: Medicinal plants in controlling Pox virus affections:Ethnopharmacology, chemistry, clinical, preclinical studies and future perspectives -- Chapter 10: Role of medicinal plants in prevention and treatment of Respiratory viral infections -- Chapter 11: Assessment of effectiveness of herbal drugs in prevention and treatment against Gastrointestinal viral diseases -- Chapter 12: Antiviral potential of medicinal plants in treatment of diseases caused by Influenza virus A: Role of secondary metabolites, clinical and preclinical studies and future perspectives -- Chapter 13: Role of medicinal plants in treatment of diseases caused by Influenza virus B and Parainfluenza virus type 3 -- Chapter 14: Ethnopharmacology, chemistry, clinical and preclinical studies focusing on the uses of herbal drugs against Polio Infections -- Chapter 15: Ethnopharmacology, chemistry, clinical and preclinical studies focusing on use of medicinal plants against SARS-CoV/Corona virus infections -- Chapter 16: Medicinal plants in controlling and treatment of diseases caused by Viral Haemorrhagic Septicaemia Virus (VHSV) -- Chapter 17:Ethnopharmacology, chemistry, Clinical and preclinical studies focusing on use of different medicinal plants against vesicular stomatitis virus (VSV) infections -- Chapter 18: Ethnopharmacology, chemistry, clinical and preclinical studies focusing on use of various medicinal plants against Human Adenovirus Type 1 infections -- Chapter 19: Medicinal plants used by traditional medical practitioner in controlling and treatment of Cutaneous viral diseases: Ethnopharmacology, chemistry, Clinical and preclinical studies -- Chapter 20: Herbal drugs and medicinal plants in controlling and treatment for the diseases caused by Dengue virus (DEN-1 & 2): Ethnopharmacology, chemistry, clinical and preclinical studies -- Chapter 21: Ethnopharmacology, chemistry, Clinical and preclinical studies focusing on use of natural medicinal plants against Neurological viral diseases -- Chapter 22: Ethnopharmacology, chemistry, clinical and preclinical studies focusing on traditional crude drugs against Encephalitis infection -- Chapter 23: Ethnopharmacology, chemistry, Clinical and preclinical studies focusing on use natural plants in the treatment of Renal syndrome caused by viruses -- Chapter 24: Natural products in controlling and treatment of cancers and genital warts caused by different viruses -- Chapter 25: Role of traditional plants in controlling and treatment of fever, joint pain and pogosta diseases caused by viruses -- Chapter 26: Natural medicinal plants used in in controlling and treatment of diseases caused by Coxsackie and Coxsackie virus B3 with possible mechanism of action and role of phytochemicals.-Chapter 27: Phytochemical, clinical and preclinical studies focusing on use Indigenous plants against Cytomegalovirus, Cytomegalovirus B1 and Epstein-Barr virus infection: Prevalence and impact on patients with haematological diseases -- Chapter 28: Flavonoids: promising natural compounds against viral infections: Ethnopharmacology, chemistry, mechanism of action, clinical, preclinical studies and future perspectives -- Chapter 29: Coumarins: emerging antiviral compounds from natural origin: Ethnopharmacology, chemistry, mechanism of action, clinical, preclinical studies and future perspectives -- Chapter 30: Antiviral potential of Curcumins: Ethnopharmacology, chemistry, clinical studies focusing on mechanism of action and future perspectives. 330 $aThis reference work covers general concepts of anti-viral metabolites, classifications, ethnopharmacology, chemistry, clinical and preclinical studies focusing on different medicinal plants against various types of viral infections. Various plants have been used in medicine since ancient times and are known for their strong therapeutic effects. The book will describe potential antiviral properties of medicinal plants against a diverse group of viruses, and provide an insight to the potential plants possess for broad-spectrum antiviral effects against emerging viral infections. The book aims to target a broad audience including virologists, molecular biologist, microbiologist and scientists working with natural products as well as researchers, students, healthcare experts involved in pharmaceutical and medical field. 410 0$aReference Series in Phytochemistry,$x2511-8358 606 $aNatural products 606 $aBotany 606 $aBotanical chemistry 606 $aPharmaceutical chemistry 606 $aNatural Products 606 $aPlant Science 606 $aPlant Biochemistry 606 $aPharmaceutics 615 0$aNatural products. 615 0$aBotany. 615 0$aBotanical chemistry. 615 0$aPharmaceutical chemistry. 615 14$aNatural Products. 615 24$aPlant Science. 615 24$aPlant Biochemistry. 615 24$aPharmaceutics. 676 $a615.7924 700 $aPal$b Dilipkumar$01437505 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910760288503321 996 $aAnti-Viral Metabolites from Medicinal Plants$93598217 997 $aUNINA